Monthly ranibizumab for nonproliferative macular telangiectasia type 2: A 12-month prospective study

Peter Charbel Issa, Robert P. Finger, Kathrin Kruse, Snke Baumller, Hendrik P.N. Scholl, Frank G. Holz

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Monthly ranibizumab for nonproliferative macular telangiectasia type 2: A 12-month prospective study'. Together they form a unique fingerprint.

Medicine & Life Sciences